The study indicated cross talk among GRP78 and NF-κB in prostate cancer cells [50], and the abrogation of GRP78 blunts the activation of NF-κB through the ATF6 branch of the UPR [51]. The gene discussed is NFKB1; the disease is prostate carcinoma.